20 Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01)

Authors :: Giuseppina Calareso
Andrea Necchi
Patrizia Giannatempo
Flavio Crippa
Nicola Nicolai
Daniele Raggi
Elena Togliardi
Roberto Salvioni
Luigi Mariani
Source :: European Urology Supplements. 15:e20
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
Single group
medicine.disease
Pazopanib
Internal medicine
medicine
In patient
Germ cell tumors
Open label
business
medicine.drug

Full Text Access

Tools